RSV is the leading cause of viral bronchiolitis and pneumonia worldwide, infecting more than 50 percent of children in their first year of life and nearly 100 percent by age 2.
OMRF scientist Gary Gorbsky, Ph.D., will use the funds to pursue general research projects related to cell division.
Alberola-Ila will investigate the role a type of white blood cell plays in mounting the body’s response against flu infection.
OMRF’s Clinical Genomics Center will now be able to offer services to clinicians.
The grants cover a range of areas, including colitis and colon cancer, sepsis, genomic tools, and outreach strategies for clinical trials.